A decrease in N-methyl-D-aspartate receptor (NMDAR) function is associated with age-related cognitive impairments. However, NMDAR antagonists are prescribed for cognitive decline associated with age-related neurodegenerative disease, raising questions as to the role of NMDAR activity in cognitive function during aging. The current studies examined effects of NMDAR blockade on cognitive task that are sensitive to aging. Young and middle-age rats were trained on the five-choice serial reaction time task (5-CSRTT) and challenged with MK-801 (0.025, 0.05, and 0.1 mg/kg or vehicle). Attention deficits were apparent in middle-age and performance of young and middle-age rats was enhanced for low doses of MK-801 (0.025 and 0.05). The beneficial effects on attention were reversed by the highest dose of MK-801. Older animals exhibited a delay-dependent impairment of episodic spatial memory examined on a delayed-matching to place water maze task. Similarly, a low dose of MK-801 (0.05 mg/kg) impaired performance with increasing delay and aged animals were more susceptible to disruption by NMDAR blockade. Despite MK-801 impairment of episodic spatial memory, MK-801 had minimal effects on spatial reference memory. Our results confirm that NMDARs contribute to rapidly acquired and flexible spatial memory and support the idea that a decline in NMDAR function contributes to the age-related impairments in cognition.
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Introduction
Cognitive aging is associated with weakening of episodic memory and executive function which, in the case of Alzheimer's disease, can progress to more severe cognitive impairments and dementia (Albert, 2011; Alexander et al., 2012) . In the case of aging, cognitive decline is associated with altered Ca 2+ regulation and impaired synaptic function, including a decrease in the function of N-methyl-D-aspartate receptors (NMDARs) (Foster, 2007 (Foster, , 2012 Foster & Norris, 1997) . The emergence of deficits in episodic memory and executive function are linked to decrease in the NMDAR-mediated synaptic responses in the hippocampus and prefrontal cortex (PFC), respectively (Foster, 2012; Foster & Norris, 1997; Guidi, Kumar, & Foster, 2015; Kumar & Foster, 2013) . Similarly, b-amyloid (Ab) impairs synaptic plasticity (Shankar et al., 2007 (Shankar et al., , 2008 Walsh et al., 2002) and rapidly decreases NMDAR responses (Dewachter et al., 2009; Lacor et al., 2007; Snyder et al., 2005) , which may contribute to the onset of memory deficits associated with the early stages of Alzheimer's disease. While the onset of impaired episodic memory is associated with synaptic dysfunction, clinical dementia is more likely related to loss of connectivity throughout the brain, including cell death (DeKosky & Scheff, 1990; Scheff, Price, Schmitt, DeKosky, & Mufson, 2007; Terry et al., 1991) . Similarly, while a decline in NMDAR activation could underlie disruption of synaptic function early in Alzheimer's disease, over activation of NMDARs may contribute to cell death. The idea that NMDAR activity contributes to neurotoxicity provides a basis for use of NMDAR antagonists to treat Alzheimer's disease in order to limit the progression of cell loss (Lipton, 2006; Rogawski & Wenk, 2003) . However, there is considerable confusion concerning the utility of NMDAR modulators to treat cognitive aging and Alzheimer's disease. The low affinity activity-dependent NMDAR channel antagonist, memantine, has had mixed success in treating the symptoms of dementia and the progression of the disease (Schneider, Dagerman, Higgins, & McShane, 2011) .
There are several reasons to predict that NMDAR blockade will have detrimental effects on cognition in older animals. In young animals, NMDAR antagonists impair the rapid acquisition and
